TELA Bio reports second quarter 2024 financial results and reiterates full year 2024 revenue guidance

Posted on August 12, 2024 by Vaseline

MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on delivering innovative solutions for soft tissue reconstruction, today reported financial results for the second quarter ended June 30, 2024.

Recent highlights

Related Posts

Truck tractor overturned during towing on the A1

My children cannot be forgotten

Vogtländerin develops “Kauf beim Bauer” app